Craig Jurasinski, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Stone Harbor Blvd, Cape May Court House, NJ 08210 Phone: 609-463-2000 |
Lawrence A. Virgilio, M.D. Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 2 Stone Harbor Blvd, Cape May Court House, NJ 08210 Phone: 609-463-2755 |
News Archive
Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the companies have entered into a strategic collaboration for the further clinical development and commercialization of CMX157.
In a study that could help one day give a literal meaning to food for thought, researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce memory degradation in mice treated to simulate Alzheimer's disease.
Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.
Researchers at the Faculty of Pharmaceutical Sciences at the University of Copenhagen have collaborated with the company NeuroSearch to generate new knowledge about an important part of the brain's complex communication system.
› Verified 3 days ago